Cheng Kong Shih
Directeur Général chez Xuanzhu Biopharmaceutical Co., Ltd.
Profil
Cheng Kong Shih is currently the Vice Chairman, Chief Scientist & General Manager at Xuanzhu Biopharmaceutical Co., Ltd.
He started this position in 2021.
Prior to his current role, he obtained a doctorate degree from The Rockefeller University.
Postes actifs de Cheng Kong Shih
| Sociétés | Poste | Début |
|---|---|---|
Xuanzhu Biopharmaceutical Co., Ltd.
 Xuanzhu Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xuanzhu Biopharmaceutical Co., Ltd. engages in the research and development of chemical and biological drugs. Its products include small molecular chemical drugs, monoclonal antibodies, bispecific antibodies, and antibody conjugated drugs. The company was founded in 2002 and is headquartered in Shijiazhuang, China. | Directeur Général | 01/12/2018 |
Formation de Cheng Kong Shih
| The Rockefeller University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Xuanzhu Biopharmaceutical Co., Ltd.
Xuanzhu Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xuanzhu Biopharmaceutical Co., Ltd. engages in the research and development of chemical and biological drugs. Its products include small molecular chemical drugs, monoclonal antibodies, bispecific antibodies, and antibody conjugated drugs. The company was founded in 2002 and is headquartered in Shijiazhuang, China. | Commercial Services |
